Total planned funding: $545,832,563
Clear active filters
HTXD: Treatment: ARV Drugs
Unknown
2005
2006
2007
2008
2009
2010
2011
2012
2013
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $109,198,566 |
Uganda | $105,480,590 |
Nigeria | $69,099,486 |
South Africa | $54,665,242 |
Zambia | $41,043,159 |
Ethiopia | $39,834,134 |
Rwanda | $22,135,128 |
Botswana | $22,092,025 |
Haiti | $16,250,865 |
Côte d'Ivoire | $15,841,525 |
Mozambique | $15,597,962 |
Tanzania | $12,270,732 |
Vietnam | $9,747,619 |
Namibia | $5,074,753 |
Guyana | $3,852,097 |
Zimbabwe | $1,735,843 |
Cameroon | $516,056 |
Lesotho | $300,000 |
Eswatini | $263,194 |
Western Hemisphere Region | $239,224 |
Malawi | $182,611 |
China | $100,000 |
Cambodia | $94,366 |
Papua New Guinea | $57,440 |
Dominican Republic | $48,986 |
Burundi | $40,000 |
Central Asia Region | $26,020 |
Ukraine | $25,824 |
Democratic Republic of the Congo | $19,116 |
Organizational Types
Unknown | $545,832,563 |
Program Areas
Treatment | $545,832,563 |
Budget Codes
HTXD: Treatment: ARV Drugs | $545,832,563 |
Top Partner Programs
Not Available:
$540,120,988
View countries
Ministry of Finance and Development Planning - Botswana:
$1,837,028
View countries
All Countries
2020 | $1,837,028 |
Pharmacie de la Santé Publique de Côte d’Ivoire:
$1,135,112
View countries
All Countries
2020 | $1,135,112 |